Development of tissue-engineered substitutes of the ear ossicles: PORP-shaped poly(propylene fumarate)-based scaffolds cultured with human mesenchymal stromal cells

Journal of Biomedical Materials Research - Part A

Volumn 92, Issue 4, 2010, Pages 1343-1356

  Danti, Serena ^a   D'Alessandro, Delfo ^a   Pietrabissa, Andrea ^a   Petrini, Mario ^a   Berrettini, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Bone tissue engineering; Human mesenchymal stromal cells (hMSC); Ossicles; Partial ossicular replacement prosthesis (PORP); Poly(propylene fumarate) (PPF)

Indexed keywords

ALKALINE PHOSPHATASE; BONE TISSUE ENGINEERING; COLLAGEN I; DIACRYLATES; EXPRESSION PATTERNS; GLYCOSAMINOGLYCANS; IN-VITRO; MATRIX; MESENCHYMAL STROMAL CELLS; MICRO CT; MIDDLE EARS; OSTEOBLASTIC DIFFERENTIATION; OSTEOGENIC; POLYPROPYLENE FUMARATE; PORE INTERCONNECTIVITY; QUALITATIVE ANALYSIS;

BIODEGRADABLE POLYMERS; BONE; CALCIUM; COMPUTERIZED TOMOGRAPHY; GENE EXPRESSION; PHOSPHATASES; PROPYLENE; PROSTHETICS; SCAFFOLDS;

TISSUE ENGINEERING;

ACRYLIC ACID DERIVATIVE; FUMARIC ACID; POLY(PROPYLENE FUMARATE); POLY(PROPYLENE FUMARATE)DIACRYLATE; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ARTICLE; AUDITORY OSSICLE; CELL MATURATION; HUMAN; HUMAN CELL; MESENCHYME; OSTEOBLAST; PARTIAL OSSICULAR REPLACEMENT PROSTHESIS; POROSITY; PROSTHESIS; STROMA CELL; TISSUE ENGINEERING;

BIOCOMPATIBLE MATERIALS; BONE SUBSTITUTES; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CROSS-LINKING REAGENTS; FUMARATES; HUMANS; MATERIALS TESTING; MESENCHYMAL STEM CELLS; OSSICULAR PROSTHESIS; OSTEOGENESIS; POLYPROPYLENES; STROMAL CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 77349120552     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32447     Document Type: Article

References (46)

1. Barr ML, Kiernan JA. The Human Nervous System: An Anatomical Viewpoint, 7th ed. Philadelphia, NY: JB Lippincott-Raven; 1998. p 382.
2. Anson BJ, Donaldson JA. Surgical Anatomy of the Temporal Bone, 3rd ed. London: WB Saunders Company; 1981. p 38.
3. Fumagalli Z. Ricerche morfologiche sull'apparato di trasmissione del suono. Milano: Deca; 1947. p 12.
4. Dormer KJ, Gan RZ. Biomaterials for implantable middle ear hearing devices. Otolaryngol Clin North Am. 2001;34:289-297.
5. Tos M. Manual of Middle Ear Surgery, Vol. 1. New York: Thieme Medical Publishers; 1993. p 239.
6. Sellari-Franceschini S, Piragine F, Bruschini P, Berrettini S. TORPs and PORPs: Causes of failure. Am J Otol 1987;6:551-552.
7. Bruschini P, Berrettini S, Sellari Franceschini S, Segnini G, Piragine F. Cartilage heterografts in middle ear surgery. Transpl Impl Otol 1995;III:161-163.
8. Chole RA, Kim H-J. Ossiculoplasty with presculpted banked cartilage. Oper Tech Otolaryngol Head Neck Surg 1996;7:38-44.
9. Pyle GM. Ossicular sculpting for conductive hearing loss. Oper Tech Otolaryngol Head Neck Surg 2003;14:237-242.
10. Janeke JB, Shea JJ. Self stabilizing Proplast total ossicular replacement prosthesis in timpanoplasty. Laryngoscope 1975; 85:1550.
11. Zenner HP, Stegmaier A, Lehner R, Baumann I, Zimmermann R. Open tübingen titanium prostheses: A prospective clinical trial. Otol Neurotol 2001;22:582-589.
12. Ho SY, Battista RA, Wiet RJ. Early results with titanium ossicular implants. Otol Neurotol 2003;24:149-152.
13. Gardner EK, Jackson CG, Kaylie DM. Results with titanium ossicular reconstruction prostheses. Laryngoscope 2004;114: 65-70.
14. Martin AD, Harner SG. Ossicular reconstruction with titanium prostheses. Laryngoscope 2004;114:61-64.
15. Grote JJ. Reconstruction of the ossicular chain with hydroxylapatite imlplants. Ann Oto Rhinol Laryn 1986;95:10.
16. Wehrs RE. Hydroxyapatite implants for otologic surgery. Otolaryngol Clin North Am 1995;28:273-286.
17. Goldenberg RA, Driver M. Long-term results with hydroxylapatite middle ear implants. Otolaryngol Head Neck Surg 2000;122:635-642.
18. Rondini-Gilli E, Bozorg Grayeli A, Fernando Tormin Borges Corsara P, El Garem H, Mosnier I, Boucarra D, Sterkers O. Ossiculoplasty with total hydroxylapatite prostheses: Anatomical and functional outcomes. Otol Neurotol 2003;24:543-547.
19. Tran YH, Ohsaki K, Ii K, Ye Q, Yokozeki M, Moriyama K. Histological reaction of auditory bulla bone to synthetic auditory ossicle (Apaceram) in rats. J Med Invest 2000;47:56-60.
20. Goldenberg RA. Ossiculoplasty with composite prostheses. PORP and TORP. Otolaryngol Clin North Am 1994;27:727-745.
21. Muschler GF, Nakamoto C Griffith LG. Engineering principles of clinical cell-based tissue engineering. Review. J Bone Joint Surg Am 2004;86:1541-1558.
22. Fisher JP, Holland TA, Dean D, Engel PS, Mikos AG. Synthesis and properties of photocross-linked poly(propylene fumarate) scaffolds. J Biomater Sci Polym Ed 2001;12:673-687.
23. Timmer MD, Carter C, Ambrose CG, Mikos AG. Fabrication of poly(propylene fumarate)-based orthopaedic implants by photocrosslinking through transparent silicone molds. Biomaterials 2003;24:4707-4714.
24. Timmer MD, Ambrose CG, Mikos AG. Evaluation of thermal-and photo-crosslinked biodegradable poly(propylene fumarate)-based networks. J Biomed Mater Res A 2003;66:811-818.
25. Timmer MD, Horch RA, Ambrose CG, Mikos AG. Effect of physiological temperature on the mechanical properties and network structure of biodegradable poly(propylene fumarate)-based networks. J Biomater Sci Polym Ed 2003;14;369-382.
26. Fisher JP, Holland TA, Dean D, Mikos AG. Photoinitiated crosslinking of the biodegradable polyester poly(propylene fumarate). Part II: In vitro degradation. Biomacromolecules 2003;4:1335-1342.
27. Timmer MD, Ambrose CG, Mikos AG. In vitro degradation of polymeric networks of poly(propylene fumarate) and the crosslinking macromer poly(propylene fumarate)-diacrylate. Biomaterials 2003;24:571-577.
28. Timmer MD, Shin H, Horch RA, Ambrose CG, Mikos AG. In vitro cytotoxicity of injectable and biodegradable poly (propylene fumarate)-based networks: Unreacted macromers, cross-linked networks, and degradation products. Biomacromolecules 2003;4:1026-1033.
29. Peter SJ, Miller ST, Zhu G, Yasko AW, Mikos AG. In vivo degradation of a poly(propylene fumarate)/beta-tricalcium phosphate injectable composite scaffold. J Biomed Mater Res 1998;4:1-7.
30. Hedberg EL, Kroese-Deutman HC, Shih CK, Crowther RS, Carney DH, Mikos AG, Jansen JA. In vivo degradation of porous poly(propylene fumarate)/poly(DL- lactic-co-glycolic acid) composite scaffolds. Biomaterials 2005;26:4616-4623.
31. Mistry AS, Cheng SH, Yeh T, Christenson E, Jansen JA, Mikos AG. Fabrication and in vitro degradation of porous fumarate-based polymer/alumoxane nanocomposite scaffolds for bone tissue engineering. J Biomed Mater Res A 2008;89: 68-79.
32. Moore MJ, Jabbari E, Ritman EL, Lu LC, Currier BL, Windebank AJ, Yaszemski MJ. Quantitative analysis of interconnectivity of porous biodegradable scaffolds with micro-computed tomography. J Biomed Mater Res A 2004;71A:258-267.
33. Tuan HS, Hutmacher DW. Application of micro CT and computation modeling in bone tissue engineering. Comput Aided Design 2005;37:1151-1161.
34. Shi X, Sitharamana B, Pham QP, Liang F, Wua K, Billups WE, Wilson LJ, Mikos AG. Fabrication of porous ultra-short single-walled carbon nanotube nanocomposite scaffolds for bone tissue engineering. Biomaterials 2007;28:4078-4090.
35. Hacker M, Ringhofer M, Appel B, Neubauer M, Vogel T, Young S, Mikos AG, Blunk T, Göpferich A, Schulz MB. Solid lipid templating of macroporous tissue engineering scaffolds. Biomaterials 2007;28:3497-3507.
36. Danti S, D'Acunto M, Trombi L, Berrettini S, Pietrabissa A. A micro/nanoscale surface mechanical study on morpho-functional changes occurred to multilineage-differentiated human mesenchymal stem cells. Macromol Biosci 2007;7:589-598.
37. Singer VL, Jones LJ, Yue ST, Haugland RP. Characterization of PicoGreen reagent and development of a fluorescence-based solution assay for double-stranded DNA quantitation. Anal Biochem 1997;249:228-238.
38. Taylor SR, Titus-Ernstoff L, Stitely S. Central values and variation of measured nuclear DNA content in imprints of normal tissues determined by image analysis. Cytometry 1989;10:382-387.
39. Di Silvio L, Gurav N. Osteoblasts. In: Koller MR, Palsson BO, Masters JRW, editors. Human Cell Culture. London, UK: Kluwer Academic Publishers; 2001. p 221-241.
40. Bretaudiere J-P, Spillman T. Alkaline phosphatases, routine method. In: Bergmeyer HU, Bergmeyer J, Graßl M, editors. Methods of Enzymatic Analysis. Deerfield Beach, FL: Verlag Chemie; 1984. p 75-82.
41. Holtorf HL, Jansen JA, Mikos AG. Flow perfusion culture induces the osteoblastic differentiation of marrow stromal cell-scaffold constructs in the absence of dexamethasone. J Biomed Mater Res A 2005;72:326-334.
42. Cerri PS, Sasso-Cerri E. Staining methods applied to glycol methacrylate tissue sections. Micron 2003;34:365-372.
43. Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 2005;26:5474-5491.
44. Woo C, Li H, Baatrup A, Krause A, Kassem M, Bunger C, Lind M. Effects of bone protein extract on human mesenchymal stem cells proliferation and differentiation. J Biomed Mater Res A 2006;79:552-556.
45. Ager MJ, Feser T, Denck H, Krauspe R. Proliferation and osteogenic differentiation of mesenchymal stem cells cultured onto three different polymers in vitro. Ann Biomed Eng 2005;33:1319-1332.
46. Fisher JP, Dean D, Engel PS, Mikos AG. Photoinitiated polymerization of biomaterials. Annu Rev Mater Res 2001;31:171-181.